Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril valsartan after atrial fibrillation ablation
ChiCTR2000034257Phase 4Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sacubitril + valsartan in Atrial fibrillation (AFib) (3 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: NT-proBNP. Started Jun 2020; status: recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR2000034257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034257.